By January 1, 2010, what did the Board of Pharmacy need to create regarding controlled substances?

The Board of Pharmacy was required to create an electronic system for monitoring controlled substances by January 1, 2010, in order to enhance the tracking and management of these substances. This initiative aimed to improve patient safety and reduce the potential for abuse and diversion of controlled substances. The electronic monitoring system allows for real-time tracking, which is crucial for timely interventions when necessary and to prevent prescription fraud.

Establishing such a system aligns with broader trends in healthcare towards digitization and increased accountability, supporting a more effective approach to managing controlled substances, including reducing prescription medication abuse and ensuring compliance with regulations. This requirement reflects a significant shift from outdated practices and acknowledges the importance of technology in modern pharmacy practice.